The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
Open accessAbstract
Introduction: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. Methods: A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in South-West Cameroon. A mixed-methods approach was used. Associations between infection levels, skin disease and adherence to CDTI were assessed using mixed regression modelling. Different community members’ perception and acceptability of the CDTI strategy was explored using semi-structured interviews. Results: Onchocerciasis prevalence was 44.4% among 9456 participants. 17.5% of adults were systematic non-adherers and 5.9% participated in ≥75% of CDTI rounds. Skin disease affected 1/10 participants, including children. Increasing self-reported adherence to CDTI was associated with lower infection levels in participants aged ≥15 years but not in children. Adherence to CDTI was positively influenced by perceived health benefits, and negatively influenced by fear of adverse events linked with economic loss. Concern of lethal adverse events was a common reason for systematic non-adherence. Conclusion: CDTI alone is unlikely to achieve elimination in those high transmission areas where low participation is commonly associated with the fear of adverse events, despite the current quasi absence of high-risk levels of loiasis. Such persisting historical memories and fear of ivermectin might impact adherence to CDTI also in areas with historical presence but current absence of loiasis. Because such issues are unlikely to be tackled by CDTI adaptive measures, alternative strategies are needed for onchocerciasis elimination where negative perception of ivermectin is an entrenched barrier to community participation in programmes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationLymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686
Self-citation
Cited by
Mechanical Strain and Bone Cell Function: A Review
Ehrlich, P. J., & Lanyon, L. E. (2002) · Osteoporosis International · doi:10.1007/s001980200095 · Cited by 512
Metadata
- Authors
- Forrer, A., Wanji, S., Obie, E. D., Nji, T. M., Hamill, L., Ozano, K., Piotrowski, H., Dean, L., Njouendou, A. J., Ekanya, R., Ndongmo, W. P. C., Fung, E. G., Nnamdi, D.-B., Abong, R. A., Beng, A. A., Eyong, M. E., Ndzeshang, B. L., Nkimbeng, D. A., Teghen, S., Suireng, A., Ashu, E. E., Kah, E., Murdoch, M. M., Thomson, R., Theobald, S., Enyong, P., Turner, J. D., & Taylor, M. J.
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2021-01
- Volume
- 6
- Issue
- 1
- Pages
- e003248
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W3120766993
- Cited by
- 161
- References
- 2
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon. https://app.cochat.ai/papers/10.1136/bmjgh-2020-003248
- The paper
- Forrer, A., Wanji, S., Obie, E. D., Nji, T. M., Hamill, L., Ozano, K., Piotrowski, H., Dean, L., Njouendou, A. J., Ekanya, R., Ndongmo, W. P. C., Fung, E. G., Nnamdi, D.-B., Abong, R. A., Beng, A. A., Eyong, M. E., Ndzeshang, B. L., Nkimbeng, D. A., Teghen, S., . . . Taylor, M. J. (2021). Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon. BMJ Global Health. https://doi.org/10.1136/bmjgh-2020-003248
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.